Close

Depomed (DEPO): September Rx Data Increases Confidence - Janney

October 14, 2016 9:41 AM EDT Send to a Friend
Janney Montgomery Scott analyst, Ken Trbovich, reiterated his Buy rating on shares of DepoMed Inc (NASDAQ: DEPO) after Horizon (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login